...
首页> 外文期刊>Clinical and vaccine immunology: CVI >Development of a Poliovirus Neutralization Test with Poliovirus Pseudovirus for Measurement of Neutralizing Antibody Titer in Human Serum
【24h】

Development of a Poliovirus Neutralization Test with Poliovirus Pseudovirus for Measurement of Neutralizing Antibody Titer in Human Serum

机译:脊髓灰质炎病毒伪病毒对脊髓灰质炎病毒中和试验的研制,用于测定人血清中的中和抗体滴度

获取原文

摘要

In the Global Polio Eradication Initiative, laboratory diagnosis plays a critical role by isolating and identifying poliovirus (PV) from the stool samples from acute flaccid paralysis (AFP) cases. In recent years, reestablishment of PV circulation in countries where PV was previously eliminated has occurred because of decreased herd immunity, possibly due to poor vaccination coverage. To monitor the vulnerability of countries to PV circulation, surveillance of neutralizing-antibody titers against PV in susceptible populations is essential in the end game of the polio eradication program. In this study, we have developed a PV neutralization test with type 1, 2, and 3 PV pseudoviruses to determine the neutralizing-antibody titer against PV in human serum samples. With this test, the neutralizing-antibody titer against PV could be determined within 2 days by automated interpretation of luciferase signals without using infectious PV strains. We validated the pseudovirus PV neutralization test with 131 human serum samples collected from a wide range of age groups (ages 1 to >60 years) by comparison with a conventional neutralization test. We found good correlation in the neutralizing-antibody titers determined by these tests. These results suggest that a pseudovirus PV neutralization test would serve as a safe and simple procedure for the measurement of the neutralizing-antibody titer against PV.
机译:在全球根除脊髓灰质炎行动中,实验室诊断通过从急性弛缓性麻痹(AFP)病例的粪便样本中分离和鉴定脊髓灰质炎病毒(PV)发挥关键作用。近年来,由于牛群免疫力下降(可能是由于疫苗接种覆盖率较差),在先前已取消PV的国家中恢复了PV循环。为了监测各国对PV循环的脆弱性,在消灭脊髓灰质炎计划的最终结果中,监测易感人群中针对PV的中和抗体滴度至关重要。在这项研究中,我们开发了用1型,2型和3型PV假病毒进行的PV中和测试,以确定人血清样品中针对PV的中和抗体滴度。通过该测试,可以在2天内通过自动解释萤光素酶信号来确定针对PV的中和抗体滴度,而无需使用感染性PV菌株。通过与常规中和测试进行比较,我们使用了从131个年龄段(1至> 60岁)收集的131个人血清样本验证了伪病毒PV中和测试。我们在通过这些测试确定的中和抗体滴度中发现了良好的相关性。这些结果表明,假病毒PV中和测试将作为一种安全,简单的方法来测量针对PV的中和抗体效价。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号